US–Nigeria center to expand HPV and hepatitis B vaccination for cancer prevention
US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)
This project uses community ideas and local training to help more people in Nigeria get HPV and hepatitis B vaccines that can prevent cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11405472 on NIH RePORTER |
What this research studies
You would see researchers working with local health teams to bring vaccines into neighborhoods, schools, and clinics using ideas gathered directly from communities. People may be invited to join open-call events to share solutions or take part in apprenticeship programs that train health workers in better ways to deliver vaccines. The team will pilot and refine these community-driven delivery approaches and track how well they reach eligible people. The center also trains local researchers so future vaccine programs can be sustained.
Who could benefit from this research
Good fit: Ideal participants include adolescents, parents, community members, and health workers in Nigerian areas where HPV and hepatitis B vaccination rates are low.
Not a fit: People already fully vaccinated, those living outside participating Nigerian communities, or patients with cancers not preventable by HPV or HBV vaccination are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, this work could increase vaccination rates and reduce future preventable cancers in Nigeria.
How similar studies have performed: Community engagement and implementation strategies have improved vaccine uptake in other settings, though applying crowdsourced solutions and apprenticeship models at this scale in Nigeria is relatively novel.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.